ALDH1B1 promotes mitochondrial γ-butyrobetaine biosynthesis and fatty acid oxidation in colorectal cancer
Authors:
- Zhiping FengZFZhiping Feng
- Thomas E. BearroodTBThomas E. Bearrood
- Sydney L. CampbellSCSydney L. Campbell
- Adrianne M. KinseyAKAdrianne M. Kinsey
- Nedas MatulionisNMNedas Matulionis
- Che-Hong ChenCCChe-Hong Chen
- Takuya SeikeTSTakuya Seike
- Logan LeakLLLogan Leak
- A. Kaan TarhanATA. Kaan Tarhan
- Scott J. DixonSDScott J. Dixon
- Daria Mochly-RosenDMDaria Mochly-Rosen
- Heather R. ChristofkHCHeather R. Christofk
Preprint
Abstract
Metabolic reprogramming is a hallmark of cancer cells, and stem-like populations often upregulate aldehyde dehydrogenases (ALDHs). Functional studies have established essential roles for individual ALDH isoforms in tumor initiation, progression, and metastasis; however, the mechanisms by which these enzymes promote malignancy remain poorly understood. Here we show that aldehyde dehydrogenase 1B1 (ALDH1B1), a mitochondrial enzyme highly expressed in colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC), generates γ-butyrobetaine (GBB) and γ-aminobutyric acid (GABA) in CRC cells. The biosynthesis of both aminocarboxylic acids has been attributed to the cytosolic enzyme ALDH9A1, and we demonstrate that mitochondrial GBB and GABA are functionally distinct from the cytosolic pools of these metabolites. We further demonstrate that mitochondrial GBB can function as an antiport substrate of carnitine-acylcarnitine translocase (CACT), the transporter that mediates fatty acid uptake into the mitochondrial inner matrix. This activity complements the role of cytosolic GBB as the biosynthetic precursor to carnitine. Accordingly, ALDH1B1 can markedly enhance mitochondrial fatty acid oxidation (FAO), a catabolic process that has been linked to CRC and PDAC stemness, progression, and metastasis. Our findings reveal an unexpected role for ALDH1B1 in carnitine metabolism, GABA biosynthesis, and FAO and illustrate how the compartmental reprogramming of metabolic pathways can promote tumor growth.Keywords
Funding Information
- National Institutes of Health (R01 CA244334)
- National Institutes of Health (R35 GM127030)
- National Institutes of Health (R01 GM122923)
- National Institutes of Health (R01 AA011147)
- National Institutes of Health (R01 CA215185)
- National Institutes of Health (T32 GM136631)
- American Cancer Society (DOI: 10.53354/ACS.PF-23-1152298-01-TBE.pc.gr.175372)
- Department of Chemical and Systems Biology, Stanford University (Collaborative Research Seed Grant)
This publication has 96 references indexed in Scilit:
- Human ALDH1B1 Polymorphisms may Affect the Metabolism of Acetaldehyde and All-trans retinaldehyde—In Vitro Studies and Computational ModelingPharmaceutical Research, 2014
- The Role of Human Aldehyde Dehydrogenase in Normal and Cancer Stem CellsStem Cell Reviews and Reports, 2010
- Carnitine Biosynthesis: Identification of the cDNA Encoding Human γ-Butyrobetaine HydroxylaseBiochemical and Biophysical Research Communications, 1998
- Bacterial Overexpression, Purification, and Reconstitution of the Carnitine/Acylcarnitine Carrier from Rat Liver MitochondriaBiochemical and Biophysical Research Communications, 1998
- Human Aldehyde Dehydrogenase E3 Isozyme Is a Betaine Aldehyde DehydrogenaseBiochemical and Biophysical Research Communications, 1995
- The reconstituted carnitine carrier from rat liver mitochondria: evidence for a transport mechanism different from that of the other mitochondrial translocatorsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1994
- Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehydeBiochemical Pharmacology, 1992
- Characterization of the unidirectional transport of carnitine catalyzed by the reconstituted carnitine carrier from rat liver mitochondriaBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- The mechanism of fatty acid uptake by heart mitochondria: An acylcarnitine‐carnitine exchangeFEBS Letters, 1975
- On the biosynthesis and degradation of carnitineBiochemical and Biophysical Research Communications, 1961